2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis

Alendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseases

“…[5] Alendronate, a bisphosphonate, has been recommended for use in preventing GIOP. [6] However, the efficacy and safety of alendronate in preventing GIOP in patients with rheumatic diseases remains controversial.…”

Incremental Costs in Giant Cell Arteritis

“…Due to prolonged CS therapy, GCA patients are particularly prone to osteoporotic complications, especially women . This is why the French Health Authorities recommend drugs to combat osteoporosis in this context . Interestingly, our study showed significantly more reimbursement for proton‐pump inhibitors.…”

Evaluation of Calcium Homeostasis in Patients Treated in Ternopil University Hospital for Chronic Obstructive Pulmonary Disease

“…osteoporosis is the most prevalent bone disorder and affects about every second adult over 50. the significance of the disease is dictated by its incapacitative potential and increased mortality rate of affected individuals [4]. according to European statistics data, during 2010, femoral fractures were diagnosed in 620000 patients: 574000 individuals had fractures of forearm, 250000 -proximal humerus, and 620000 -fractures of the vertebrae, in both men and women of 50 years of age and older, with clinical osteoporosis as the major contributing factor.…”